Estimating influenza vaccine effectiveness using routinely collected laboratory data.
about
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyEffectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communitiesEffectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Contribution of the IMIA Primary Healthcare Working Group.Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in EnglandEffectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort.Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewEffectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP)Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study.Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season.Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions.Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren).
P2860
Q21144621-033D3B5C-42FF-4D82-AC07-DA8F7F3D4FC2Q28741469-C1A980B9-CB23-4D2B-B6BB-438308924AE7Q30357697-785A299D-7F2C-4E73-BBF3-1DC7C5DA5848Q30365708-21C7C19A-EA74-464E-859F-477A4BF5B187Q30386260-40912AE2-CC59-4B25-9E34-33A636109AFAQ30397257-C4A93245-F9A2-4113-8CDA-8AA3CAE4F1A4Q30404923-BDCC73FC-C808-4919-BB8C-040AC7F3D4DFQ30410112-7F9BA607-100B-4F2D-B0CD-36FDCCC82BB1Q30417900-CFF43841-A960-436F-908D-173A709C6241Q33931144-53B0AA1C-DCA0-4D5F-BA3C-273E8579D7F8Q34033876-C490BE20-C4C7-474D-9DFA-8BA678696EC2Q34778408-4192319F-1BB0-48B4-9086-5B1E820E20A9Q34993133-54C5D163-11D3-4BB4-A15C-27E5DA15AA70Q35014268-29BBFFBC-DA6F-4776-9A95-3A0CADB95AA5Q35803937-8FDF5C11-6239-4E54-A158-69813B7EAACBQ35914703-F9DDE5A1-7EA6-4148-A7BE-209F85B6F905Q36368673-6977578D-874A-4BF9-83E8-FC7A06E500C8Q36396691-F5FE0B57-73B5-48FF-A143-E83BFD4FBD4CQ37355265-DEB874D2-5F0B-4C55-AA95-F766F1BE5CE0Q40802753-C4C0B451-21AC-4268-A119-F6FB4394E3A1Q44131613-74C544C1-7D00-499C-861F-23B4B071CFEBQ45167252-3AC7BA72-D3B7-44E8-A582-3DF6319A038AQ47133339-E4C5F31C-9908-4A33-8883-B96FD72F225DQ47154049-C33C966F-287B-481B-8084-E6FD2CB3A1E4Q47627481-18A8E7A0-BE85-4E41-B4D1-831BF8736BFCQ52845428-A7004CA5-870B-4852-836C-47DD7B9D8C88
P2860
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@ast
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@en
type
label
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@ast
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@en
prefLabel
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@ast
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@en
P2093
P356
P1476
Estimating influenza vaccine effectiveness using routinely collected laboratory data.
@en
P2093
A Bermingham
A J Elliot
D M Fleming
N J Andrews
P Sebastianpillai
P304
P356
10.1136/JECH.2009.093450
P577
2009-11-12T00:00:00Z